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ABSTRAK 
 
Gamma-tokotrienol (GTT) telah menunjukkan aktiviti antitumor yang signifikan terha-
dap pelbagai sel tumor. Penemuan terdahulu menunjukkan bahawa GTT mempunyai 
kesan antiproliferasi terhadap sel kanser hepar (HepG2) pada nilai IC50 170 μM. Di 
dalam kajian ini, kaedah elektroforesis gel dua dimensi (2DE) digunakan bagi menge-
tahui perubahan pada ekspresi protein di dalam sel HepG2 selepas rawatan GTT. Tu-
juan utamanya adalah untuk mengenalpasti mekanisme molekul yang mungkin terlibat 
dalam aktiviti antitumor GTT. Penumpuan diberikan kepada penghasilan profil protein 
2DE sel HepG2 dengan dan tanpa rawatan GTT. Analisis awal terhadap profil 2DE, 
menunjukkan terdapat 18 titik protein diekspreskan secara berlainan di dalam sel di-
rawat GTT. Pemerhatian ini dipastikan dengan meluaskan lagi skop kajian kami ke-
pada saiz sampel yang lebih besar. Dengan mengkaji kesan rawatan GTT kepada 
ekspresi protein di dalam sel HepG2, mekanisme asas yang terlibat pada sifat anti tu-
mor secara diferensial GTT mungkin boleh dijelaskan. 
 
Kata kunci:  Proteomik, elektroforesis gel dua dimensi (2DE), Gamma-tokotrienol 
(GTT), sel HepG2 
 
 
ABSTRACT  
 
Gamma-tocotrienol (GTT) has been shown to exhibit significant antitumor activity in a 
variety of tumor cells. Previous findings have demonstrated that GTT had antiprolifera-
tive effects on a liver cancer cell line (HepG2) with an IC50 value of 170μM. In this 
study, two dimensional gel electrophoresis (2DE) was used to determine changes in 
protein expression in HepG2 cell line following treatment with GTT. The ultimate aim is 
to identify the possible molecular mechanisms involved in GTT antitumor activity. This 
study is focused on obtaining a 2DE protein profile for HepG2 cell line with and without 
GTT treatment. In the preliminary analysis of the resulting 2DE profiles, 18 protein 
spots were found to be differentially expressed in cells treated with GTT. This observa-
tion is confirmed by extending the analysis to a larger sample size. By studying the 
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effects of GTT treatment on differential protein expression in HepG2 cells the underly-
ing mechanisms involved in the antitumor activity of GTT may be elucidated. 
 
Key words: Proteomics, two dimensional gel electrophoresis (2DE), Gamma-tocotrie-
nol (GTT), HepG2 cells 
 
 
 
INTRODUCTION  
 
Vitamin E has been reported to have an-
ticancer properties in both animal models 
and cells in culture (Nesaretnam et al. 
1995). The vitamin E usually studied is α-
tocopherol but recently more studies 
have focused on tocotrienol, isomers of 
vitamin E present in large quantities in 
palm oil. The tocotrienols are reported to 
be stronger antioxidants than α-tocophe-
rol. In addition tocotrienols have proper-
ties which are different from α-tocophe-
rol. In this laboratory, GTT have been 
shown to have antiproliferative effect 
against a variety of cell lines particularly 
liver cancer cells with an IC50 of 170 μM 
(Aida et al. 2007). 
Among the tocotrienol group, delta-to-
cotrienol and gamma-tocotrienol are con-
sidered to have the strongest inhibitory 
effects on cancer cell growth (Sakai et al. 
2004). Gamma-tocotrienol (GTT) has 
also been shown to exhibit antiprolifera-
tive properties on other tumor cells in 
culture, such as breast cancer cells 
(Nesaretnam et al. 1995), murine mela-
noma cells (He et al. 1997), human leu-
kemia cells (Mo & Elson 1999) and ma-
lignant mammary epithelial cells (Shah & 
Sylvester 2005).  
Several possible mechanisms of the 
antiproliferative effect of GTT have been 
suggested such as its involvement in in-
ducing antioxidant effects (Noguchi et al. 
2003; Calvisi et al. 2004), suppressive 
effects on HMG-CoA reductase activity 
(Parker et al. 1993; Mo & Elson 2004), 
pro-apoptotic effects (Agarwal et al. 
2004; Shun et al. 2004), regulating mito-
genesis (Mo & Elson 1999) and anti-an-
giogenic potential (Miyazawa et al. 2004). 
In a recent and more elaborate study, it 
was shown that GTT inhibits the nuclear 
factor κB activation pathway, leading to 
down-regulation of various gene products 
and potentiation of apoptosis (Ahn et al. 
2007). However, most of these mechan-
isms have only been studied on other 
types of tumor cells in particular breast 
cancer cell lines and specific pathways 
have not been fully characterized. To 
further understand the mechanisms in-
volved in the anti-proliferative effects of 
GTT, it would be of interest to identify 
proteins whose expression are effected 
by exposure of HepG2 a liver cancer cell 
line to GTT treatment by using two-di-
mensional gel electrophoresis (2DE).  
Proteomics has evolved into a robust 
and highly reliable method allowing re-
searchers to profile cellular responses to 
various physiological and pathological 
conditions at the protein level. Currently it 
has been successfully employed in the 
area of cancer research, particularly in 
the search for new biomarkers (Cho 
2007). Apart from that, it has also been 
utilized in the analysis of the response of 
tumor cells to an antitumor substance 
(Stockwin et al. 2007; Tong et al. 2008; 
Scheper et al. 2008). The majority of pre-
vious studies showed changes in the ex-
pression of proteins involved in the cel-
lular processes such as apoptosis and 
proteins that are directly associated with 
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tumor development characteristic of the 
type of cancer (Yim et al. 2004; Mouat et 
al. 2005; Li et al. 2006; Tong et al. 2008). 
In this study, 2DE was used to charac-
terize changes in protein expression lev-
els in HepG2 cell line following treatment 
with GTT. By identifying the specific al-
terations in the cellular protein profile in 
response to GTT treatment, the underly-
ing mechanisms involved in the anti-pro-
liferative activity of GTT may be eluci-
dated. 
 
MATERIALS AND METHODS 
 
Cell culture and treatment 
 
HepG2 and WRL68 cell lines were pur-
chased from American Type Culture 
Collection (ATCC, USA). Cells were 
maintained in Eagle minimum essential 
medium (EMEM, Flowlab, Australia) 
containing 10% foetal calf serum (PAA, 
Austria), penicillin/ streptomycin (100 
μg/ml) (Flowlab, Australia) at 37°C in an 
atmosphere containing 5% CO2. 
Gamma-tocotrienol (GTT) was supplied 
by Malaysian Palm Oil Board (MPOB). 
Stock solution of GTT (0.5 M) was pre-
pared in 100% ethanol and stored as 
small aliquots at -20ºC. Prior to use, GTT 
from stock solution was mixed with foetal 
calf serum and incubated overnight at 
37ºC. Culture medium and 100% ethanol 
were then added to give a final concen-
tration of 70 μM. When the cells reached 
confluency, they were trypsinized, cen-
trifuged and counted using a haemocy-
tometer. Cells were plated at a density of 
2 x106 cells/100-mm culture plates for 24 
hrs and incubated with 10 mL of 70 μM 
GTT enriched medium for 48 hours. As a 
negative control, cells were cultured in 
EMEM without GTT.  
 
Sample Preparation for 2DE 
 
At the end of the treatment period, cells 
were harvested by trypsinization and 
transferred into 15 ml Falcon centrifuge 
tubes. The cells were harvested by cen-
trifugation at 800 rpm for 10 minutes. 
They were then washed thrice with cold 
PBS and the resulting pellet resuspended 
in 200 μl lysis buffer (8M urea, 2% 
CHAPS, 0.5% pH 3-10 IPG buffer, 
Amersham, USA) containing protease 
inhibitor mix (Amersham, USA). The cells 
were then incubated on ice for 30 min-
utes with intermittent vortexing at 10 
minute intervals. After centrifugation at 
13000 rpm for 30 minutes at 4oC, the su-
pernatant was transferred to sterile mi-
crocentrifuge tubes. Protein concentra-
tion was determined as described by 
Bradford (1976). 
 
Two-dimensional Gel Electrophoresis 
  
First dimension separation was carried 
out on immobilized pH gradient strips (24 
cm, linear, pH 3-10, GE Healthcare) with 
Ettan IPGphor II Isoelectric Focusing 
System and standard strip holder (GE 
Healthcare). Isoelectric focusing (IEF) 
was performed under the following con-
ditions: 500V for 1 hour, 1000V for 1 
hour, 8000V for 3 hours and finally 
8000V for 3 to 4 hours. Protein samples 
(60 μg) were loaded into sample cups at 
the anode end. Upon completion of IEF, 
strips were equilibrated in equilibration 
buffer (6M urea, 75 mM Tris-HCl, pH 8.8, 
29.3% Glycerol, 2% SDS, 0.002% bro-
mophenol blue, 1% DTT) for 15 minutes, 
followed by the same buffer containing 
25% iodoacetamide instead of DTT for 
another 15 minutes. The second dimen-
sion separation was carried out at 15oC 
on 12.5% SDS slab gels using an ETTAN 
DALT II electrophoresis system (GE 
Healthcare), with the IPG strips sealed 
on the top of the gels with 0.5% agarose. 
SDS-PAGE was run at constant power of 
1 W/gel for 1 hour, then switched to 13 
W/gel until the bromophenol blue marker 
reached the bottom of the gel. For every 
treatment group, triplicate runs were 
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made to ensure the accuracy of subse-
quent analysis. 
 
Gel Staining and Image Analysis 
 
Protein spots were visualized by silver 
staining as described in the PlusOne Sil-
ver Staining Kit (GE Healthcare). Images 
of stained 2DE-gels were acquired with a 
UMAX scanner, model UTA-2100 XL and 
stored as TIFF images. The 2DE maps 
were then analyzed using the 2D Image 
Master Platinum software Version 6.0 
(GE Healthcare). The volume of each 
spot in a gel was normalized as a per-
centage of the total volume of all spots 
detected on the gel. Only those spots 
that were consistently changed (more 
than 2-fold) were selected as spots of 
interest in this study. 
 
RESULTS 
 
The proteome profile obtained from the 
analysis was highly reproducible between 
different runs and different sample sets. 
Representative gels are shown in Figure 
1 and Figure 2. A total of ~500 individual 
protein spots were detected with silver 
staining. Following image analysis, a total 
of 83 spots were identified as being dif-
ferentially expressed following GTT 
treatment. Out of the 83 spots, only 18 
individual protein spots were differentially 
expressed in a consistent manner in 
every triplicate gel, and therefore, were 
selected as spots of interest in this study. 
These spots are shown in Figure 3.  
 
DISCUSSION 
 
In general, the 2DE gels were highly re-
producible in terms of spot number, spot 
intensity and general protein profile. 
There were minimal intra and inter-sam-
ple variation among the 2DE gels. Con-
sistency and reproducibility were 
achieved by standardized procedures of 
sample preparations of cells cultured, 
conditions for first and second dimen-
sions of electrophoresis, gel staining and 
image acquisition. During sample prepa-
ration, a protease inhibitor cocktail was 
used. With the use of this inhibitor cock-
tail, resulting 2DE gels did not show any 
signs of protein degradation due to pro-
tease activity (as evidenced by the high 
resolution of high molecular weight pro-
teins).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Representative 2D gel image of HepG2 
cells without GTT treatment. Range of horizontal 
axis is from 3 to 10 pH units (left to right), while full 
range of vertical axis is from 10 to 250 kDa (bottom 
to top). 
Figure 2: Representative 2D gel image of HepG2 
cells with GTT treatment. Range of horizontal axis 
is from 3 to 10 pH units (left to right), while full 
range of vertical axis is from 10 to 250 kDa (bottom 
to top). 
pH 10 pH 3 pH 10 pH 3 
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U, untreated HepG2 cell; T, treated HepG2 cell 
(+), upregulated expression; (-), downregulated expression 
 
Figure 3:  Annotated 2DE map of HepG2. The boxed labels show the spot number and expression dynamics 
of the proteins of interest in this study. 
 
Twenty four centimeter gels were used 
in order to obtain the best possible reso-
lution for 2DE. A sample loading of 80μg 
protein per gel resulted in 2DE profiles 
with saturated protein spots which may 
lead to inaccuracies during quantitative 
analysis. A representative gel of an 80μg 
protein load is shown in Figure 4. To re-
solve this problem, a sample loading of 
60μg protein per gel was used. This was 
found to be ideal for resolving the highest 
number of spots without sacrificing gel 
resolution. Image analysis revealed that 
there were no saturated spots present at 
this protein loading therefore ensuring 
that image analysis would remain quan-
titative. Thus at this point, we have es-
tablished a robust and reliable protocol 
for the 2DE analysis of the proteome of 
HepG2 cell lines. We then moved on and 
performed differential proteomics analy-
sis of treated and untreated HepG2 cell 
lines. 
A total of 18 differentially expressed 
protein spots were identified following 
treatment of HepG2 cells with GTT. 
Among the protein spots, 7 of them (spot 
no 1, 2, 3, 4, 5, 6 and 18) are acidic (pI < 
5) proteins. Of these seven, protein spot 
numbered 1 has the largest molecular 
weight (>90 kDa), while protein spot 
numbered 18 is the smallest sized pro-
260 
 
Gamma-tocotrienol Alters Protein Expression of HepG2 Cell Line Med & Health 2008; 3(2): 256-262 
tein with molecular weight around 10 
kDa. The rest (spot no 2, 3, 4, 5 and 6) 
are medium-sized proteins with a mo-
lecular weight ranging from 30 to 50 kDa. 
A group of 8 protein spots (spot no 8, 9, 
10, 11, 12, 13, 14 and 15) are found ac-
cumulated in the middle of the 2D-PAGE 
gel of both group of HepG2 cells (with 
and without GTT treatment). All of these 
proteins have a molecular weight ranging 
from 35 to 60 kDa. The pI of these pro-
teins could vary from slightly acidic, neu-
tral, to slightly basic. This cannot be con-
firmed because all the proteins were too 
close between each other. Another two 
(spots no 7 and 16) are assumed as 
slightly basic proteins since they were 
both well-separated on the slightly basic 
region of the 2D-PAGE gel. These spots 
were large proteins with the molecular 
weight around 60 to 90 kDa. The last 
protein from the 18 differentially ex-
pressed proteins were highly basic pro-
teins with spot numbered 17 as average-
sized protein (around 30 kDa). These 
observations showed that the changes in 
protein expression occur over a wide pH 
and molecular weight range and were not 
localized to any specific region of the gel. 
This was expected as treatment with 
GTT will most likely affect a wide variety 
of proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Representative 2D gel image of HepG2 
cells with 80 μg protein loading. Saturated protein 
spots are shown by the arrows. 
Interestingly, all of these 18 protein 
spots were observed only in HepG2 cells 
without GTT treatment and not in the 
HepG2 cells with the GTT treatment. In 
other words, these proteins were greatly 
decreased to the extent that they were no 
longer detectable in the 2D protein profile 
of HepG2 cells with GTT treatment. 
Whether these proteins are directly re-
lated to the antiproliferative activity of 
GTT remains unclear as we have yet to 
identify these proteins. 
Our results demonstrated that GTT 
treatment caused specific and significant 
changes in the 2DE profile of the HepG2 
cell line. Proteins generally function in 
groups that are involved in many biologi-
cal pathways simultaneously. Thus, any 
interventions will ultimately affect the 
regulation and/or modulation of not only 
one but many proteins simultaneously. 
This has been continuously demon-
strated in various studies of the intracel-
lular mechanisms of various drugs. One 
example is the study conducted by Ahn 
et al. (2007), demonstrated that GTT 
suppressed NF-κB activation pathway 
and NF-κB-regulated gene products. As 
in our study, the unknown proteins that 
are involved might be associated with the 
anti-tumor activity of GTT in HepG2 cells. 
Thus, further identification of these pro-
teins by mass spectrometry may lead to 
a greater understanding of the mecha-
nisms involved in the anti-proliferative 
effects of GTT. 
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